BioSpace News Archive

Blue Earth Diagnostics Highlights Presentations on Axumin ® (Fluciclovine F 18) and 18 F-Fluciclovine at Upcoming ASTRO Annual Meeting

FSD Pharma Inc. announced today it has entered into an agreement with Covar Pharmaceuticals Inc. (“Covar”), a contract development and manufacturing services organization (“CDMO”), to commence work on providing research quantities of FSD’s drug candidate, Lucid-PSYCH, on an exclusive basis for further clinical evaluation.

Medical technology innovator Ivenix collaborated with Eastman to incorporate Eastman Tritan ™ MXF copolyester into its groundbreaking Ivenix Infusion System.

Molecular Assemblies, Inc., today announced that it has been awarded a $250,000 Phase I Small Business Innovation Research (SBIR) grant (Award No. R43HG011679) from the National Human Genome Research Institute (NHGRI) at the U.S. National Institutes of Health (NIH)

Molecular Targeting Technologies, Inc. (MTTI) announce publication of their Spray technology in ACS Sensors, entitled “Near-Infrared Fluorogenic Spray for Rapid Tumor Sensing.”

Oncolytics Biotech® Inc. announced that it will host a conference call and webcast on Friday, November 5, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the third quarter of 2021.

Varian, a Siemens Healthineers company, a leading provider of cancer care technologies and solutions, will demonstrate the power of intelligent cancer care to shape the future of oncology during the 2021 American Society for Radiation Oncology (ASTRO) taking place in Chicago, Illinois, October 24-27.

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, announced today that it has publicly filed an F-1 Registration Statement (File No.: 333-260338) with the U.S. Securities and Exchange Commission relating to a proposed U.S. initial public offering.

Rosalind Franklin University of Medicine and Science researcher William Frost, PhD, director of the Stanson Toshok Center for Brain Function and Repair within the university’s Brain Science Institute, has been awarded a $1.95 million grant from the National Institutes of Health to study how the brain develops and sustains focus when responding to novel stimuli.

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced its Trial Interactive eClinical innovation team will be leading and participating in three TMF-focused sessions at the 10th Annual Trial Master File Summit.